ATE549624T1 - Verfahren und zusammensetzungen zur diagnose und behandlung von grippe - Google Patents

Verfahren und zusammensetzungen zur diagnose und behandlung von grippe

Info

Publication number
ATE549624T1
ATE549624T1 AT06786341T AT06786341T ATE549624T1 AT E549624 T1 ATE549624 T1 AT E549624T1 AT 06786341 T AT06786341 T AT 06786341T AT 06786341 T AT06786341 T AT 06786341T AT E549624 T1 ATE549624 T1 AT E549624T1
Authority
AT
Austria
Prior art keywords
pdz
methods
compositions
influenza
influenza virus
Prior art date
Application number
AT06786341T
Other languages
English (en)
Inventor
Peter S Lu
Joshua D Rabinowitz
Michael P Belmares
Original Assignee
Arbor Vita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Vita Corp filed Critical Arbor Vita Corp
Application granted granted Critical
Publication of ATE549624T1 publication Critical patent/ATE549624T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06786341T 2005-07-01 2006-07-03 Verfahren und zusammensetzungen zur diagnose und behandlung von grippe ATE549624T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69622105P 2005-07-01 2005-07-01
US72637705P 2005-10-13 2005-10-13
US76529206P 2006-02-02 2006-02-02
US79227406P 2006-04-14 2006-04-14
PCT/US2006/026155 WO2007018843A2 (en) 2005-07-01 2006-07-03 Methods and compositions for diagnosis and treatment of influenza

Publications (1)

Publication Number Publication Date
ATE549624T1 true ATE549624T1 (de) 2012-03-15

Family

ID=37307088

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06786341T ATE549624T1 (de) 2005-07-01 2006-07-03 Verfahren und zusammensetzungen zur diagnose und behandlung von grippe

Country Status (8)

Country Link
US (2) US7595151B2 (de)
EP (1) EP1910837B1 (de)
JP (1) JP2009500611A (de)
AT (1) ATE549624T1 (de)
AU (1) AU2006276813A1 (de)
CA (1) CA2613482A1 (de)
IL (1) IL188460A (de)
WO (1) WO2007018843A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510824B2 (en) * 1999-06-02 2009-03-31 Nono Inc. Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
US7595297B2 (en) * 1999-06-02 2009-09-29 Michael Tymianski Method of reducing injury to mammalian cells
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US7595152B2 (en) * 2005-07-01 2009-09-29 Arbor Vita Corporation Detection of influenza virus
CA2613482A1 (en) * 2005-07-01 2007-02-15 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
AU2007217765A1 (en) * 2006-02-21 2007-08-30 Nanogen, Inc. Methods and compositions for analyte detection
US20100028855A1 (en) * 2006-10-21 2010-02-04 Arbor Vista Corporation Detection of influenza virus type b
RU2337703C1 (ru) * 2007-03-06 2008-11-10 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Средство профилактики и лечения вирусных заболеваний и способ профилактики и лечения вирусных заболеваний
ES3045958T3 (en) * 2007-07-17 2025-12-01 Somalogic Operating Co Inc Method for generating aptamers with improved off-rates
WO2009015384A1 (en) * 2007-07-26 2009-01-29 University Of Rochester Nucleic acid binding compounds and methods of use
US8163474B2 (en) * 2008-03-15 2012-04-24 Arbor Vita Corporation NS1-NP diagnostics of influenza virus infection
CN101649356B (zh) * 2009-07-24 2012-09-05 浙江省疾病预防控制中心 甲型h1n1流感病毒荧光定量检测试剂盒及检测方法
KR101341640B1 (ko) * 2010-02-05 2013-12-16 한국전자통신연구원 단백질 미세 구조 분석 방법 및 단백질 미세 구조 분석용 어레이
WO2011146825A2 (en) * 2010-05-20 2011-11-24 The Board Of Trustees Of The University Of Arkansas Avian influenza h5n1 specific aptamers and their use
US9217137B2 (en) * 2011-08-12 2015-12-22 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for specific regulation of pyruvate dehydrogenase kinase
CA2796520A1 (en) 2011-11-18 2013-05-18 Thelial Technologies S.A. Method for identifying cancer drug candidates in drosophila
WO2013106909A1 (en) * 2012-01-18 2013-07-25 Governing Council Of The University Of Toronto Novel peptides and methods and uses thereof for preventing retinal disorders
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR101471245B1 (ko) * 2012-05-31 2014-12-10 충북대학교 산학협력단 A형 인플루엔자 바이러스 감염 질환의 예방 및 치료용 조성물
US9493542B2 (en) * 2013-02-22 2016-11-15 Augusta University Research Institute, Inc. Methods of using ERBB2 conjugate peptides
US20140329706A1 (en) * 2013-05-01 2014-11-06 California Institute Of Technology Affinity tags, and related affinity ligands, engineered proteins, modified supports, compositions, methods and systems
JP2018128408A (ja) * 2017-02-10 2018-08-16 東ソー株式会社 抗体凝集体形成予測方法
EP3983804B1 (de) * 2019-06-13 2025-08-06 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Reagenzien und schnelle verfahren zur pathogencharakterisierung und serologieuntersuchung
US11549114B2 (en) * 2020-03-27 2023-01-10 Apollo Biomedical, LLC Multiple rapid detection kits and methods for various viruses
WO2021188569A1 (en) * 2020-03-17 2021-09-23 Detect, Inc. Rapid diagnostic test with blister pack
CN111410694B (zh) * 2020-03-27 2020-12-22 浙江省人民医院 一种抗胶质瘤的多肽分子及其应用
WO2022018622A1 (en) * 2020-07-20 2022-01-27 United Arab Emirates University Method and system for virus and protein-antibody interactions detection and monitoring based on optical light intensity and electrical parameters

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO870613L (no) 1986-03-05 1987-09-07 Molecular Diagnostics Inc Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.
AU620330B2 (en) 1987-05-29 1992-02-20 Smithkline Beckman Corporation Immunodiagnostic assays using chimeric antigens
JP2897959B2 (ja) 1988-05-20 1999-05-31 エフ.ホフマン―ラ ロシュ アクチェンゲゼルシャフト 固定化された配列特異的プローブ
US5856092A (en) 1989-02-13 1999-01-05 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
ES2109945T3 (es) 1990-06-01 1998-02-01 Chiron Corp Composiciones y procedimientos para identificar moleculas biologicamente activas.
US5846710A (en) 1990-11-02 1998-12-08 St. Louis University Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5888819A (en) 1991-03-05 1999-03-30 Molecular Tool, Inc. Method for determining nucleotide identity through primer extension
GB9502489D0 (en) * 1995-02-09 1995-03-29 Animal Health Trust Expression of the non-structural protein NS1 of influenza virus and detection of anti-NS1 antibody in serum
AU2001277986A1 (en) * 2000-07-25 2002-02-05 Axcell Biosciences Corporation Identification and isolation of novel polypeptides having pdz domains and methods of using same
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
JP4426122B2 (ja) * 2001-01-23 2010-03-03 株式会社ビーエル 血中抗原検出方法及び装置
US20030119203A1 (en) * 2001-12-24 2003-06-26 Kimberly-Clark Worldwide, Inc. Lateral flow assay devices and methods for conducting assays
BR0314155A (pt) * 2002-09-09 2005-07-05 Arbor Vita Corp Métodos para diagnosticar câncer cervical
JP2004161685A (ja) * 2002-11-14 2004-06-10 Bl:Kk 卵黄関連蛋白およびその用途
JP2004166564A (ja) * 2002-11-19 2004-06-17 Bl:Kk モノクローナル抗体および結核症診断法
EP1664781B1 (de) * 2003-09-22 2013-05-08 Quidel Corporation Vorrichtungen zum nachweis mehrerer analyte in einer probe
JP2006067979A (ja) 2004-09-06 2006-03-16 Bl:Kk インフルエンザa型ウイルスの免疫検出法
US7595152B2 (en) * 2005-07-01 2009-09-29 Arbor Vita Corporation Detection of influenza virus
CA2613482A1 (en) * 2005-07-01 2007-02-15 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
ATE532752T1 (de) * 2007-01-02 2011-11-15 Draka Comteq Bv Verlängertes backverfahren für abscheidungsröhrchen aus quarzglas

Also Published As

Publication number Publication date
HK1115192A1 (en) 2008-11-21
US20100112547A1 (en) 2010-05-06
US7595151B2 (en) 2009-09-29
EP1910837A2 (de) 2008-04-16
IL188460A (en) 2012-02-29
JP2009500611A (ja) 2009-01-08
WO2007018843A2 (en) 2007-02-15
IL188460A0 (en) 2008-04-13
US20070161078A1 (en) 2007-07-12
CA2613482A1 (en) 2007-02-15
AU2006276813A1 (en) 2007-02-15
WO2007018843A3 (en) 2007-06-28
EP1910837B1 (de) 2012-03-14

Similar Documents

Publication Publication Date Title
IL188460A0 (en) Diagnostic methods and compositions for diagnosing and treating influenza
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
EA201390638A8 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
ATE501280T1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
MX340547B (es) Equipos de prueba de diagnostico.
EP2394163A4 (de) Verfahrung für den nachweis des jc-polyomavirus
EA201171046A1 (ru) Зонды и праймеры для детектирования вируса чикунгуньи
WO2007056250A3 (en) Heterogeneous assay of analytes in solution using polymers
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
WO2009108170A3 (en) Compositions and methods for determining immune status
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
WO2007005948A3 (en) Methods and compositions for diagnosis and treatment of viral and bacterial infections
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
ATE414277T1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
RU2007130566A (ru) Способ изготовления контрольного образца для дефектоскопии трубопроводов
ATE444491T1 (de) Verfahren zur bestimmung von kardiovaskulären risikofaktoren
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
ATE514794T1 (de) Zusammensetzungen und verfahren für den nachweis von enterokokken-nukleinsäuren
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome